Wrist Cooling May Help Manage Vasomotor Symptoms
WEDNESDAY, Sept. 24, 2025 -- Targeted wrist cooling may offer a safe approach for managing vasomotor symptoms, according to a study published online Sept. 20 in Endocrinology and Diabetes.
Nazlı Uçar, from the Chobanian & Avedisian School of Medicine at Boston University, and colleagues evaluated whether a wrist cooling device could serve as a safe, nonpharmaceutical intervention for reducing hot flash severity. The analysis included 27 participants (10 breast cancer patients, 12 prostate cancer patients, and five postmenopausal women) experiencing at least two daily moderate-to-severe hot flashes.
The researchers found that compared with baseline, the active cooling intervention reduced severe hot flash episodes by 46 percent and total daily hot flashes by 18 percent. There were consistent effects observed across all populations (41 percent reduction in breast cancer patients; 50 percent reduction in both postmenopausal women and prostate cancer patients). There was significant reduction seen in hot flash severity when adjusting for age and underlying condition.
"Most nonhormonal pharmaceutical options for managing hot flashes are limited by significant side effects, and hormone replacement therapy is not appropriate for breast and prostate cancer patients who were on, or who have been treated with, hormone deprivation therapy," coauthor Michael F. Holick, M.D., Ph.D., also from Boston University, said in a statement. "This creates an urgent need for safe, effective, nonpharmaceutical interventions suitable for diverse patient populations experiencing debilitating vasomotor symptoms."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
App May Improve Palliative Care for Adults With Incurable Cancer
WEDNESDAY, Sept. 24, 2025 – A palliative care educational app improves health-related quality of life (HRQoL) at two months among adult patients with incurable cancer...
Age at Start of Estrogen Therapy May Affect Alzheimer Disease Risk
WEDNESDAY, Sept. 24, 2025 -- Estrogen therapy may reduce Alzheimer disease (AD) risk, with lower risk seen in association with early initiation, according to a study presented at...
Model Based on Mammogram Features, Age Can Predict CV Risk
FRIDAY, Sept. 19, 2025 -- A deep learning model based on mammographic features and age predicts cardiovascular risk with performance comparable to traditional risk equations...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.